How to Taper Off Benzodiazepines Safely

You can come off benzodiazepines safely: slowly, on a plan, never cold turkey. Here's how a gradual taper (the Ashton method) works, and why the way out is far gentler than the agony you're picturing.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

If you want off a benzodiazepine, here is the most important thing to know first: you can get there, and the safe way is almost always slow, planned, and supervised — not sudden. Coming off too fast after regular use is what makes withdrawal dangerous. Coming off gradually is what makes it manageable.

That gradual approach has a name and a long track record. Much of modern benzodiazepine tapering traces back to the work of Professor Heather Ashton, whose clinic protocol — widely known as the Ashton Manual — laid out a patient, step-by-step method for reducing the dose over months, often by first switching to a longer-acting benzodiazepine to smooth the ride. The principle behind it now anchors clinical guidance worldwide[1].

The reassuring part, the part fear keeps hidden: most people who taper properly get off. A slow taper is not a slower version of the agony you may be picturing. It is the thing that prevents that agony.

Want off a benzo? Taper slowly, don't quit cold turkey. Call 988 if you're in danger right now.
If you’re in danger right now or thinking about suicide, call or text 988 (Suicide & Crisis Lifeline), any time.

What to do:

  • Don’t stop abruptly after regular use. Quitting a benzodiazepine cold turkey can trigger seizures and severe withdrawal — the gradual taper is exactly what prevents that, and it is far gentler than stopping alone[1].
  • Get a clinician to set the pace. Gradual, supervised tapering is the standard, recommended way to come off, and a doctor can tailor the speed to you and treat symptoms along the way[2]. Find a benzodiazepine taper program →
  • You don’t have to white-knuckle it. A planned reduction, paired with support, is what makes coming off safe — reaching out is the move that turns everything around.

Find treatment today →

AddictionHelp.com Fast Facts
  • Slow and supervised is the standard: gradual outpatient tapering is the recognized way to come off a benzodiazepine, and a clinician tailors the pace to you[2].
  • Cold turkey is the danger, not stopping itself: abrupt discontinuation after physical dependence carries a real withdrawal risk, which is the whole reason the dose is stepped down gradually[1].
  • You are not alone in this: millions take these drugs long-term — roughly 2.4 million adults in England were dispensed a benzodiazepine or Z-drug in a single year, and hundreds of thousands take them past the recommended duration[3].
  • Tapering works, and therapy makes it work better: structured deprescribing helps people reduce and stop these drugs, and pairing the taper with cognitive behavioral therapy improves the odds of staying off[4][5].

Why You Can’t Just Stop a Benzodiazepine

Dependence on a benzodiazepine is not addictionBecoming physically dependent on a benzodiazepine — needing a taper to come off without withdrawal — is expected with regular use, even taken exactly as prescribed. That is not the same as addiction, and it is not a character flaw. It simply means your body adapted, and coming off needs a plan.

Here is the plain biology, because it explains everything that follows. Take a benzodiazepine regularly and your brain adapts to its presence. The drug strengthens the brain’s main calming signal, so the brain quietly turns its own calming machinery down to keep the balance. After a while, that lowered baseline becomes the new normal — and the drug is now propping it up.

Pull the drug away all at once, and there is nothing holding the nervous system back. That is what physical dependence means, and it is why current clinical guidance treats abrupt discontinuation as a risk to manage, not a shortcut to take[1]. The challenge of coming off benzodiazepines exists precisely because of physical dependence and the withdrawal it produces[1].

Stopping Suddenly Can Be Dangerous

This is the one rule that matters most, so it gets said plainly. Stopping a benzodiazepine suddenly after regular use is the dangerous move. The withdrawal that follows abrupt discontinuation is exactly what a taper is designed to prevent[1], and in heavier or longer-term use it can turn severe. Withdrawal from chronic benzodiazepine use can include serious complications such as delirium, particularly in people who have used the drug for a long time[6].

If you read “don’t quit cold turkey” and hear “so I might as well keep taking it,” read it the other way. The point is not to stay on the drug. The point is that there is a safe road off, it is well mapped, and a slow taper is the on-ramp.

A Taper Removes the Risk, It Doesn’t Just Slow It

A gradual reduction is not a slower, drawn-out version of the same suffering. By stepping the dose down in small amounts over time, a taper gives the brain a chance to rebuild its own calming machinery before the next reduction — so the nervous system is never left fully exposed. That is why gradual tapering, not abrupt cessation, is the standard recommendation for discontinuation[2]. The slowness is the safety.

The Ashton Method and the Gradual-Taper Principle

What a benzodiazepine taper isA taper is a planned, gradual reduction of your dose over time. Instead of stopping, you step the amount down in small increments, pausing at each level long enough for your body to settle, until the dose is low enough to stop safely.

The core idea Professor Ashton put on the map is disarmingly simple: come down slowly, in small steps, on a schedule the person can actually tolerate, and don’t rush the final stretch. Decades later, that principle is the backbone of benzodiazepine tapering in clinical practice — gradual, individualized dose reduction is how discontinuation is meant to be done[2]. The newer Joint Clinical Practice Guideline on benzodiazepine tapering, developed by the American Society of Addiction Medicine with nine other medical societies, is built on the same foundation of evidence-based, gradual strategies for coming off[7].

Small Steps, Then Hold

In an Ashton-style taper, the dose comes down by a small fraction, and then you hold there. You stay at the new, lower dose until you feel reasonably steady again before making the next cut. The reductions are deliberately modest — the goal is to keep withdrawal symptoms in a tolerable range the whole way down, not to test how much you can endure.

This is also why a taper is never one-size-fits-all. A good clinician adjusts the size of each step and the time between steps to how you are actually doing, which is the heart of an individualized taper design[2]. If a step is too hard, you slow down. The schedule serves you, not the other way around.

Why Guidelines Now Recommend This

It is worth knowing how thoroughly this has been studied, because it makes the path feel less like guesswork. Clinical guidelines have long recommended limiting benzodiazepines to short courses — often just two to four weeks — yet long-term use remains common, which is exactly why so much work has gone into how to taper people off safely[1]. Internationally, prescribing and deprescribing guidance for benzodiazepines used in anxiety, depression, and insomnia has been mapped across many countries, and the shared thread is a structured, gradual reduction rather than an abrupt stop[8].

Did you know?

The push to taper isn’t about taking a useful medicine away for its own sake. Benzodiazepines were designed and approved for short-term use, and the trouble tends to start when a few weeks quietly stretch into a few years[1]. Tapering is simply the planned exit from a drug that was never meant to be a permanent fixture.

Switching to Long-Acting Diazepam to Smooth the Ride

Short-acting versus long-acting benzodiazepinesA short-acting benzodiazepine leaves the body quickly, so its level can drop sharply between doses; a long-acting one clears slowly and stays steadier. Tapering from a steady, slow-clearing drug means fewer sharp dips — which is the logic behind switching to long-acting diazepam before the reduction.

One of the most recognizable features of the Ashton approach is the diazepam switch. For people on a short-acting benzodiazepine, the dose can rise and fall sharply through the day, and those swings can themselves feel like mini-withdrawals. Switching first to a longer-acting benzodiazepine — classically diazepam (Valium) — flattens those peaks and troughs, giving a steadier blood level to taper down from.

The point of the switch is comfort and control, not speed. A long-acting drug self-smooths as it clears, so each small reduction lands more gently than the same cut would on a short-acting drug. Whether a switch is right for you, and at what equivalent dose, is a clinical decision — different drugs are not interchangeable milligram for milligram, and the conversion is something a prescriber works out with you.

When the Dose Is Compounded into Small Steps

The other practical problem with tapering is that ordinary tablets only come in a few sizes, and near the end of a taper the steps you need are smaller than any pill. Programs have solved this in a few ways. In a national tapering program in Belgium, community pharmacists compound capsules with stepwise, gradual dose reductions, so a person can step down in precise increments that off-the-shelf tablets can’t provide[9]. Liquid formulations and pill-splitting serve the same purpose. The mechanics vary; the principle is constant — make the steps small enough that the body barely notices each one.

How Slow Is Slow Enough

The pace is set by your body, not a calendarThe single best predictor of a smooth taper is matching the speed to the person. Push faster than your nervous system can re-adapt and symptoms spike; go at a pace you can tolerate and the same destination becomes manageable. Slower is not failing. Slower is the method working.

The answer is the one people least want to hear and most need to: it takes as long as it takes, and that is usually months, not days. There is no universal countdown, because the right pace depends on the drug, the dose, how long you’ve taken it, and how your body responds along the way[2].

A few honest realities shape the timeline:

  • Longer use, longer taper. Someone who has taken a benzodiazepine daily for years generally comes down more gradually than someone on it for a few months.
  • The last stretch is the slowest. Many people find the smallest doses the hardest to leave, so good tapers shrink the step size as the dose gets low rather than rushing the finish.
  • Pauses are part of the plan. Holding at a dose during a stressful stretch of life, then resuming, is normal and sensible — not a setback.

The table below shows the shape of a typical gradual taper. It is an illustration of the stepwise principle, not a prescription — your actual schedule is set by your clinician and adjusted to how you feel.

Taper stage What’s happening Typical pace
Stabilize Settle on a steady starting point, sometimes after switching to a long-acting benzodiazepine A short period before any cuts begin
Early reductions Step the dose down by a small fraction, then hold until steady Reductions spaced out over weeks
Later reductions Smaller steps as the dose gets low, with the same hold-until-steady rhythm Often slower than the early stage
Final stretch The last, smallest doses, frequently the most sensitive part The slowest steps of all

Micro-Tapering for a Gentler Descent

Some people do best taking the gradual principle to its logical end with a micro-taper — reducing by tiny amounts very frequently, sometimes daily, so no single cut is large enough to jolt the system. The idea fits neatly with how tapers are studied: in one trial design, the daily dose was reduced so gradually and discreetly that it was even masked from the patient, while behavioral support carried the rest[10][11]. Micro-tapering won’t be necessary for everyone, but for those who are sensitive to each drop, it can turn a series of hard steps into a long, gentle slope.

Why Medical Supervision Matters

Worth asking your prescriberA good opening question for the conversation: is now a reasonable time to start easing off, and what pace would you suggest for me? Benzodiazepines are built for short-term use, so raising the taper conversation early is a normal, smart move — not a confession.

You can think of a clinician as the person who carries the risk so you don’t have to. Supervised tapering is the standard not because patients can’t be trusted, but because a professional can match the pace to you, catch problems early, and adjust the plan in real time[2]. Most tapering happens successfully in the outpatient world — at home, on a schedule, with regular check-ins — which is where it belongs for the majority of people[2].

Some Situations Call for a Higher Level of Care

Most people taper safely as outpatients, but a clinician will sometimes recommend a more supported or more closely monitored setting. That makes sense for a smaller group whose situation is more complex — for example, people using several substances at once, those who have tried to taper before without success, or those with co-occurring medical or psychiatric conditions that make a faster, supervised discontinuation safer to do under observation[2].

Setting Often a fit for What it adds
Outpatient taper Most people on a stable dose with a steady home life A gradual reduction over weeks to months while you live your life[2]
Inpatient or monitored detox Multiple substances, prior failed tapers, complicating conditions Closer observation through a more rapid, structured discontinuation[2]

None of this changes the goal. Whatever the setting, the aim is the same gradual, individualized reduction — the higher level of care simply puts more eyes on a harder case. To understand the symptoms a taper is managing, see what benzodiazepine withdrawal actually involves, and if you’re unsure whether your situation is dependence or something more, the difference between dependence and addiction is worth getting clear on.

What Helps Alongside the Taper

The symptoms are the brain healing, not breakingThe anxiety and sleeplessness that surface during a taper are not proof you’re failing or that you’ll always feel this way. They are the visible sign of a nervous system rebuilding the calming machinery the drug had turned down. It is uncomfortable, and it does settle as your brain finds its footing again.

The taper is the spine, but it is not the whole body of recovery. What you do around the dose reductions has a lot to do with how the process feels — and how well it lasts.

Therapy Makes the Taper Stick

This is one of the best-supported additions to a taper, and it’s worth taking seriously. Among people with anxiety disorders, adding cognitive behavioral therapy meaningfully improves the chances of successfully discontinuing benzodiazepine anxiolytics[5]. For people taking them to sleep, psychosocial approaches — especially cognitive behavioral therapy for insomnia (CBT-I) — likewise help people get off benzodiazepine sleep aids[12]. The therapy works because it treats the very problem the drug was masking: it gives you real tools for the anxiety or the sleeplessness, so you’re not coming off into a vacuum.

Encouragingly, you may not need a huge course of it. In a tapering program, even a single session of CBT for insomnia showed promise for reducing benzodiazepine dependence, alongside fuller therapy[13]. Some help is far better than none, and a little structure goes a long way.

Sleep and Symptom Support

Sleep is often the sticking point, because insomnia is both a reason people started a benzodiazepine and a common withdrawal symptom — which can stall a taper if it isn’t addressed[14]. There are gentler tools for the gap. Melatonin has been studied specifically as an aid to coming off, with the aim of easing the insomnia that can otherwise derail discontinuation[14][15]. What helps you sleep without a benzodiazepine is a conversation worth having with your prescriber as part of the plan, not an afterthought.

Support and Structure

Coming off is easier when you are not doing it alone. Structured deprescribing programs — the organized, clinician-guided process of reducing an inappropriate long-term medication — help people actually get these drugs down and stopped[3][4]. Whether that structure comes from a doctor, a pharmacist-supported program, a therapist, or people who care about you, the through-line is the same: a plan and a support system beat willpower alone.

Did you know?

For people who aren’t ready to come off yet, stopping isn’t the only way to get safer. Harm-reduction approaches exist for benzodiazepine use too, because meeting people where they are — rather than demanding they quit or get nothing — keeps more people alive and connected to care until they’re ready to taper[16]. The door to a taper stays open.

What to Realistically Expect

A hard week is not a failed taperTapers are rarely a straight line down. Symptoms come in waves, life gets in the way, and sometimes you hold a dose longer than planned — all of that is normal, not failure. The people who finish are usually the ones who let the rough patches pass and kept going, not the ones who never had one.

It helps to walk in with accurate expectations, because the gap between what people fear and what usually happens is enormous. Here is the realistic version.

The early reductions are often easier than the later ones, and the lowest doses can be the most stubborn — which is why good tapers slow down near the end rather than speeding up to finish[2]. Symptoms tend to come in waves rather than a steady line; a hard week does not mean the taper is failing, and many people find that holding at a dose for a bit lets the wave pass. Throughout, the discomfort you feel is your nervous system re-adapting, and it eases as it does.

And the data give real grounds for optimism. Across the research, structured strategies to deprescribe these drugs are effective at helping people reduce and discontinue them[4], and that holds for older adults — the group most worried about it — where supervised approaches help people safely come off[17]. Tapering is recognized as the standard, established treatment for getting off benzodiazepines for good reason: it works[16].

You Can Get off, and the Way Out Is Gentler than You Fear

If a benzodiazepine has become something you take more out of dread of stopping than out of benefit, hold onto this: you can come off, the method is well understood, and a proper taper is far kinder than the picture in your head. Stopping abruptly is the part to avoid. A slow, planned, supervised reduction is the part that works.

The path is the same whether you took the drug exactly as prescribed or things drifted out of your hands. Don’t quit cold turkey. Get a clinician to set a gradual pace and tailor it to you. Lean on therapy, on better sleep tools, and on people who support you — those are what make the taper hold[5][3]. Start the conversation, and the cliff you’ve been staring at becomes a set of small, walkable steps.

To go deeper on what’s ahead:

The next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

How do you safely come off a benzodiazepine?

Gradually and under supervision, not all at once. Gradual outpatient tapering, where the dose is stepped down in small amounts over time, is the standard recommended way to discontinue a benzodiazepine, and the pace is individualized to the person[2]. The challenge of stopping comes from physical dependence and withdrawal risk, which is exactly what a slow taper is designed to manage[1]. Pairing the taper with cognitive behavioral therapy improves the chances of staying off[5].

What is the Ashton Manual taper method?

It is the gradual, stepwise tapering approach developed by Professor Heather Ashton, often involving a switch to a longer-acting benzodiazepine like diazepam followed by slow, individualized dose reductions over months. The principle it popularized, gradual reduction tailored to the person rather than abrupt stopping, is now the backbone of clinical guidance on benzodiazepine tapering[2]. The newer Joint Clinical Practice Guideline, developed by the American Society of Addiction Medicine with nine other societies, is built on the same evidence-based, gradual strategy[7].

Why can't I just stop taking my benzodiazepine?

Because regular use causes physical dependence, so stopping suddenly can trigger serious withdrawal. Current clinical guidance treats abrupt discontinuation as a risk to manage precisely because of that dependence and the withdrawal it produces[1]. Withdrawal from long-term use can become severe, including complications like delirium in people with chronic use[6]. A gradual taper lets your nervous system re-adapt step by step, which is what prevents the danger.

How long does it take to taper off benzodiazepines?

Usually months rather than days, and there is no universal timeline because the right pace depends on the drug, your dose, how long you have taken it, and how you respond[2]. Longer-term use generally means a slower taper, and the lowest doses are often the most sensitive, so good tapers slow down near the end rather than rushing the finish. The speed is matched to your body, and going slower is the method working, not failing.

Does therapy help when coming off benzodiazepines?

Yes, and it is one of the best-supported additions to a taper. Among people with anxiety disorders, adding cognitive behavioral therapy improves the chances of successfully discontinuing benzodiazepine anxiolytics[5], and for people using them to sleep, psychosocial approaches like CBT for insomnia help with discontinuation[12]. Even a single session of CBT for insomnia has shown promise within a tapering program[13]. Therapy works because it treats the anxiety or sleeplessness the drug was masking.

Will I actually be able to get off benzodiazepines?

For most people who taper properly, yes. Across the research, structured strategies to deprescribe these drugs are effective at helping people reduce and stop them[4], including in older adults, the group most worried about it, where supervised approaches help people come off safely[17]. You are also far from alone, since millions take these medications long-term[3]. Tapering is recognized as the standard, established treatment for getting off benzodiazepines because it works[16].

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

17 Sources
  1. Kleykamp BA, Devoto A, Lindsay D, Mazer-Amirshahi M, Brunner E, Chen CA, et al. (2026). Benzodiazepine Tapering: Evidence Limitations and Research Recommendations. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001715
  2. Karavolis Z, Hendler R, Sedgewick A, Mosquera M, McHugh RK, Kim J (2026). Inpatient Management of Benzodiazepine Withdrawal: A Narrative Review of a Systematic, Individualized Taper Design. Harvard review of psychiatry. https://doi.org/10.1097/hrp.0000000000000469
  3. Soni A, Thiyagarajan A, Reeve J (2023). Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis. Addiction (Abingdon, England). https://doi.org/10.1111/add.15997
  4. Zeraatkar D, Nagraj SK, Ling M, Jassal T, Kirsh S, Lima JP, et al. (2025). Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis. BMJ (Clinical research ed.). https://doi.org/10.1136/bmj-2024-081336
  5. Takeshima M, Otsubo T, Funada D, Murakami M, Usami T, Maeda Y, et al. (2021). Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis. Psychiatry and clinical neurosciences. https://doi.org/10.1111/pcn.13195
  6. Al-Soleiti M, Park JH, Kummerlowe MN, Kinzelman-Vesely E, Gerberi DJ, Philbrick KL, et al. (2026). Clinical Characteristics and Treatment of Benzodiazepine Withdrawal Delirium in Adults: An Illustrative Case and Systematic Review of Published Cases. Journal of the Academy of Consultation-Liaison Psychiatry. https://doi.org/10.1016/j.jaclp.2026.06.001
  7. Brunner E, Chen CA, Klein T, Maust D, Mazer-Amirshahi M, Mecca M, et al. (2025). Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. Journal of general internal medicine. https://doi.org/10.1007/s11606-025-09499-2
  8. Brandt J, Bressi J, Lê M, Neal D, Cadogan C, Witt-Doerring J, et al. (2024). Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.102507
  9. Stul F, Vanderbeken L, Lejeune L, Mehuys E, Petrovic M, Boussery K, et al. (2025). Community pharmacists' experiences with the new tapering program for benzodiazepines and Z-drugs in Belgium. Acta clinica Belgica. https://doi.org/10.1080/17843286.2025.2572344
  10. Fung CH, Alessi C, Martin JL, Josephson K, Kierlin L, Dzierzewski JM, et al. (2024). Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2024.5020
  11. Ghadimi S, Erickson AJ, Vaughan M, Mitchell MN, Josephson K, Badr MS, et al. (2026). Sleep aid usage following benzodiazepine receptor agonist tapering and cognitive behavioral therapy for insomnia in middle-aged and older adults. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. https://doi.org/10.1007/s44470-026-00089-5
  12. Takaesu Y, Utsumi T, Okajima I, Shimura A, Kotorii N, Kuriyama K, et al. (2019). Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis. Sleep medicine reviews. https://doi.org/10.1016/j.smrv.2019.101214
  13. Chapoutot M, Gustin M, Anders R, Peter-Derex L, Bastuji H, Khazaal Y, et al. (2026). Is a full psychotherapy program necessary to reduce benzodiazepine dependence for insomnia? A Randomized Controlled Trial Comparing Drug Tapering with Single-Session CBT vs. Full Acceptance and Commitment Therapy. Sleep medicine. https://doi.org/10.1016/j.sleep.2025.108744
  14. Wright A, Diebold J, Otal J, Stoneman C, Wong J, Wallace C, et al. (2015). The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis. Drugs & aging. https://doi.org/10.1007/s40266-015-0322-5
  15. Morera-Fumero AL, Fernandez-Lopez L, Abreu-Gonzalez P (2020). Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2020.107994
  16. Morrison C, Natale I, Branchflower A, Harvey C, Lundin RM (2025). Harm reduction approaches for the use of benzodiazepines: a scoping review. Harm reduction journal. https://doi.org/10.1186/s12954-025-01310-z
  17. O'Hara-Veintimilla K, Páez-García S, Ramirez-Triana J, Torres-Tello K, Verhelst-Forero P, Borda Borda MG (2026). Safety and effectiveness of strategies to deprescribe chronic benzodiazepine receptor agonist use in older adults: a systematic review. Age and ageing. https://doi.org/10.1093/ageing/afag112
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.